Join Us for Canines & Cocktails on December 10, 2026! Click Here to Buy Tickets.

01703-A: Enhancing Natural Anti-Tumor Immune Responses during Chemotherapy

Cancer is one of the leading causes of death in dogs. In dogs with cancer, suppressor T cells (Treg) prevent the elimination of cancer by suppressing killer immune cells. Dogs with cancer have significantly higher numbers of Treg when compared to healthy dogs because of stimuli secreted by the cancer. Increased numbers of Treg result […]

00947A: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma

Grant Status: Closed Grant Amount: $147,482.64 Matthew Breen, PhD; North Carolina State University August 1, 2008 – November 30, 2011 Sponsor(s): Golden Retriever Foundation Breed(s): Golden Retriever, Rottweiler Research Program Area: Oncology Donate to Support this Research Program Area Project Summary In this study we recruited 140 cases of canine osteosarcoma, representing client owned dogs […]

00336A: Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog

We are interested in finding the genes that predispose the Bernese Mountain Dog (BMD) to malignant histiocytosis (MH) for three reasons. First, we are interested in improving the health of this increasingly popular breed, which is severely affected by this deadly disease. Finding the underlying disease gene will lead to the development of genetic tests […]

01633: Novel Therapy for Melanoma, Lymphoma, Meningioma and Nephroblastoma

Spontaneous melanoma strikes an estimated 50,000 dogs each year. Even with aggressive treatment, the median survival time is < 1 year. Dr. Wilson's research group has identified a new class of drugs, S100B inhibitors, which prevent the growth of canine/human melanoma cells as well as in vivo murine tumors. Two of these inhibitors, pentamidine and […]

0002254B: Heritable and Sporadic Genetic Lesions in Canine Lymphoma and Osteosarcoma

Lymphoma (cancer of lymph glands) and osteosarcoma (bone cancer) are two common cancers of dogs with remarkable breed predisposition. Lymphoma accounts for approximately 20 percent of all canine tumors, and > 80 percent of cancers originating from blood cells. Osteosarcoma is the most common bone tumor in dogs, accounting for 85 percent of skeletal cancers. […]

01683-A: Improving Resection of Tumors through Enhanced Imaging

In spite of our improved understanding of cancer molecular biology, the majority of curative cancer treatments include surgical resection of the tumor. Inadequate resection of all cancerous tissue during surgery significantly contributes to the morbidity and mortality of the disease. When “curative” surgery is attempted but incomplete surgical margins are obtained, dogs can develop both […]

00990-A: Prognostic Indicators for Anal Sac Gland Carcinoma in the English Cocker Spaniel and Preparing to Map Predisposition to this Tumor

Grant Status: Closed Grant Amount: $12,678 David Sargan, MA, PhD; University of Cambridge July 1, 2007 – December 31, 2007 Sponsor(s): Samoyed Club of America Education & Research Foundation Breed(s): English Cocker Spaniel Research Program Area: Oncology Donate to Support this Research Program Area Project Summary The goal of this project was to perform a […]

0002254A: Heritable and Sporadic Genetic Lesions in Canine Lymphoma and Osteosarcoma

Lymphoma (cancer of lymph glands) and osteosarcoma (bone cancer) are two common cancers of dogs with remarkable breed predisposition. Lymphoma accounts for approximately 20 percent of all canine tumors, and > 80 percent of cancers originating from blood cells. Osteosarcoma is the most common bone tumor in dogs, accounting for 85 percent of skeletal cancers. […]